Clinical Therapeutics: In Which Patients with COPD Should Ensifentrine be Added to Standard Therapy?

Abstract

Despite advances in inhaled bronchodilator therapy, many patients with Chronic Obstructive Pulmonary Disease (COPD) remain symptomatic and experience activity limitation despite appropriate use of long-acting β?-agonists (LABAs), Long-Acting Muscarinic Antagonists (LAMAs), and Inhaled Corticosteroids (ICS).